Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,757 public trials 649 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China

NCT02600221

Conditions
Asthma, Asthma-COPD Overlap Syndrome, Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome, +12 more
Locations
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Chongqing, Chongqing Municipality, China
  • Research Site Guangzhou, Guangdong, China
  • Research Site Haikou, Hainan, China
View all 13 locations
View Trial Details
Completed

Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT02260986

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Phoenix, Arizona, United States
  • Hot Springs, Arkansas, United States
  • Little Rock, Arkansas, United States
  • Encinitas, California, United States
View all 148 locations
View Trial Details
Completed

Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)

NCT01639040

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Berlin, Germany
  • Dresden, Germany
  • Dülmen, Germany
  • Frankfurt, Germany
View all 13 locations
View Trial Details
Completed

Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma

NCT02586506

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Aventura, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component

NCT02164539

Conditions
Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Upland, California, United States
  • GSK Investigational Site Sunset, Louisiana, United States
View all 67 locations
View Trial Details

Related conditions